Please login to the form below

Not currently logged in
Email:
Password:

Antares Pharma appoints LeRoux Jooste SVP pharma sales and marketing

Joins US self-injection and topical gel specialists from Cephalon

Cephalon's LeRoux Jooste has joined Antares Pharma as senior VP pharma sales and marketing.

He has experience in product planning and portfolio management in multiple therapeutic areas including endocrinology and rheumatology, and has worked with such products as Prozac, Ceclor and Gemzar during his 25-year career in healthcare.

“LeRoux brings to Antares a proven track record in leading sales and marketing organisations, launching new products and managing alliance partners,” said Dr Paul Wotton, president and CEO of Antares.

“In particular, LeRoux's experience working at Cephalon will be beneficial to Antares as we continue to grow this Company in an intelligent and focused way.”

During his time at biopharma Cephalon, LeRoux's most senior position was VP commercial assessment and new product planning, working his ways up from leadership positions in sales and marketing as well as commercial operations.

Previously, he was with Nabi Biopharmaceuticals as senior VP global sales and marketing after serving as chief operating officer of Aton Pharma.

Earlier in his career he held positions with Wyeth Pharmaceuticals and Eli Lilly & Company.

“The company is currently working to commercialize Vibex MTX and I'm looking forward to playing a pivotal role in that process,” said LeRoux.

“A successful launch will enable Antares to continue to build commercial capabilities for the recently announced Vibex QS T, potentially the first auto injector testosterone product for men suffering from symptomatic testosterone deficiency.”

16th May 2012

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

A snapshot of… Exscientia
...
Patients are ready for virtual clinical trials, are you?
Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid...
Keep your audiences close
How getting up close and personal with target audiences can fuel creativity...

Infographics